Expression of alpha-dystroglycan correlates with tumour grade and predicts survival in oral squamous cell carcinoma

Pathology

Volumn 42, Issue 3, 2010, Pages 248-254

  Sgambato, A ^a   Caredda, E ^a   Leocata, P ^b   Rossi, G ^c   Boninsegna, A ^a   Vitale, A ^b   Grandi, T ^c   Cittadini, A ^a   Migaldi, M ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Dystroglycan; Oral cancer; Oral squamous carcinoma; Prognostic marker; Tumorigenesis

Indexed keywords

EID: 77950330013     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.3109/00313021003631361     Document Type: Article

References (28)

1. Kademani D. Oral cancer. Mayo Clin Proc 2007; 82: 878-887
2. Parkin D, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
3. Hunter K, Parkinson E, Harrison P. Profiling early head and neck cancer. Nat Rev Cancer 2005; 5: 127-135
4. Massano J, Regateiro F, Januario G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 67-76.
5. Winder SJ. The complexities of dystroglycan. TIBS 2001; 26: 118-124
6. Sgambato A, Brancaccio A. The dystroglycan complex: from biology to cancer. J Cell Physiol 2005; 205: 163-169
7. Durbeej M, Campbell KP. Biochemical characterization of the epithelial dystroglycan complex. J Biol Chem 1998; 274: 26609-26616
8. Henry MD, Campbell KP. A role for dystroglycan in basement membrane assembly. Cell 1998; 95: 859-870
9. Durbeej M, Talts JF, Henry MD, Yurchenco PD, Campbell KP, Ekblom P. Dystroglycan binding to laminin a1LG4 module influences epithelial morphogenesis of salivary gland and lung in vitro. Differentiation 2001; 69: 121-134
10. Muschler J, Levy D, Boudreau R, Henry M, Campbell K, Bissell MJ. A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. Cancer Res 2002; 62: 7102-7109
11. Sgambato A, Di Salvatore M, De Paola B,et al. Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis. J Cell Physiol 2006; 207: 520-529
12. Henry MD, Cohen MB, Campbell KP. Reduced expression of dystroglycan in breast and prostate cancer. Hum Pathol 2001; 32: 791-795
13. Herzog C, Has C, Franzke C-W,et al. Dystroglycan in skin and cutaneous cells: b-subunit is shed from the cell surface. J Invest Dermatol 2004; 122: 1372-1380
14. Jing J, Lien CF, Sharma S, Rice J, Brennan PA, Gorecki DC. Aberrant expression,processing and degradation of dystroglycan in squamous cell carcinomas. Eur J Cancer 2004; 40: 2143-2151
15. Losasso C, Di Tommaso F, Sgambato A,et al. Anomalous dystroglycan in carcinoma cell lines. FEBS Letters 2000; 484: 194-198
16. Sgambato A, Migaldi M, Montanari M,et al. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol 2003; 162: 849-860
17. Singh J, Itahana Y, Knight-Krajewski S,et al. Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. Cancer Res 2004; 64: 6152-6159
18. Calogero A, Pavoni E, Gramaglia T,et al. Altered exression of adystroglycan subunit in human gliomas. Cancer Biol Ther 2006; 5: 441-448
19. Sgambato A, Camerini A, Amoroso D,et al. Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma. Cancer Biol Ther 2007; 6: 1840-1846
20. Sgambato A, De Paola B, Migaldi M,et al. Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells. J Cell Physiol 2007; 213: 528-539
21. Sgambato A, Camerini A, Montanari M,et al. Increased expression of dystroglycan inhibits the growth and tumorigenicity of human mammary epithelial cells. Cancer Biol Ther 2004; 3: 849-860
22. Brennan P, Jing J, Ethunandan M, Gorecki D. Dystroglycan complex in cancer. Eur J Surg Oncol 2004; 30: 589-592
23. World Health Organization. International Classification of Diseases. Geneva: IARC Press, 2005.
24. AJCC (American Joint Committee on Cancer). AJCC Cancer Staging Manual. New York: Springer-Verlag, 2002.
25. Sgambato A, Tarquini E, Resci F,et al. Aberrant expression of alphadystroglycan in cervical and vulvar cancer. Gynecol Oncol 2006; 103: 397-404.
26. Esapa CT, Bentham GR, Schroder JE, Kroger S, Blake DJ. The effects of post-translational processing on dystroglycan synthesis and trafficking. FEBS Lett 2003; 555: 209-216
27. de Bernabé D, Inamori K, Yoshida-Moriguchi T,et al. Loss of alphadystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. J Biol Chem 2009; 284: 11279-11284
28. Gui GPH, Puddefoot JR, Vinson GP, Wells CA, Carpenter R. Altered cell-matrix contact: a prerequisite for breast cancer metastasis? Br J Cancer 1997; 75: 623-633